Publicaciones en colaboración con investigadores/as de Hospital Universitario Arnau de Vilanova (64)

2024

  1. Sprouty1 is a broad mediator of cellular senescence

    Cell Death and Disease, Vol. 15, Núm. 4

2023

  1. Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness

    Molecular Oncology, Vol. 17, Núm. 1, pp. 98-118

  2. PKN1 Kinase: A Key Player in Adipocyte Differentiation and Glucose Metabolism

    Nutrients, Vol. 15, Núm. 10

2022

  1. Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer

    Cancers, Vol. 14, Núm. 12

2020

  1. T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma

    Journal of Investigative Dermatology, Vol. 140, Núm. 6, pp. 1253-1265

2019

  1. Cytoplasmic cyclin D1 regulates glioblastoma dissemination

    Journal of Pathology, Vol. 248, Núm. 4, pp. 501-513

  2. Sympathetic Hyperactivity and Sleep Disorders in Individuals With Type 2 Diabetes

    Frontiers in Endocrinology, Vol. 10

  3. Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis

    Journal of Pathology, Vol. 247, Núm. 1, pp. 72-85

2017

  1. Endometrial carcinoma: Specific targeted pathways

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 149-207

2016

  1. 2-phenylethynesulphonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels

    Pigment Cell and Melanoma Research, Vol. 29, Núm. 3, pp. 352-371

  2. Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-κB Pathway in Endometrial Cancer

    Molecular Imaging and Biology, Vol. 18, Núm. 4, pp. 545-556

  3. Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer

    Oncotarget, Vol. 7, Núm. 19, pp. 26979-26991

  4. Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism

    Oncotarget, Vol. 7, Núm. 32, pp. 52364-52374

2015

  1. Impaired Vitamin D signaling in endothelial cell leads to an enhanced leukocyte-endothelium interplay: Implications for atherosclerosis development

    PLoS ONE, Vol. 10, Núm. 8

  2. Modeling glands with PTEN deficient cells and microscopic methods for assessing PTEN loss: Endometrial cancer as a model

    Methods, Vol. 77, pp. 31-40

2014

  1. A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry

    Human Pathology, Vol. 45, Núm. 12, pp. 2394-2403

  2. Combinatorial therapy using dovitinib and ICI182.780 (Fulvestrant) blocks tumoral activity of endometrial cancer cells

    Molecular Cancer Therapeutics, Vol. 13, Núm. 4, pp. 776-787

  3. FISH analysis of PTEN in endometrial carcinoma: Comparison with SNP arrays and MLPA

    Histopathology, Vol. 65, Núm. 3, pp. 371-388

  4. Role of local bioactivation of vitamin D by CYP27A1 and CYP2R1 in the control of cell growth in normal endometrium and endometrial carcinoma

    Laboratory Investigation, Vol. 94, Núm. 6, pp. 608-622

2013

  1. Endometrial carcinoma: Molecular alterations involved in tumor development and progression

    Oncogene, Vol. 32, Núm. 4, pp. 403-413